EUDA Health Holdings Limited (NASDAQ:EUDA – Get Free Report) was the recipient of a significant decrease in short interest during the month of July. As of July 31st, there was short interest totaling 2,417 shares, a decrease of 52.4% from the July 15th total of 5,079 shares. Currently, 0.1% of the company’s stock are short sold. Based on an average daily volume of 5,465 shares, the days-to-cover ratio is presently 0.4 days.
EUDA Health Stock Up 2.3%
Shares of EUDA traded up $0.32 during trading hours on Friday, reaching $14.32. 836 shares of the stock traded hands, compared to its average volume of 5,688. EUDA Health has a 52 week low of $5.26 and a 52 week high of $86.00. The stock has a fifty day simple moving average of $14.93 and a 200 day simple moving average of $14.63.
Hedge Funds Weigh In On EUDA Health
A hedge fund recently bought a new position in EUDA Health stock. Jane Street Group LLC bought a new stake in EUDA Health Holdings Limited (NASDAQ:EUDA – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 25,675 shares of the company’s stock, valued at approximately $59,000. Jane Street Group LLC owned approximately 0.07% of EUDA Health as of its most recent SEC filing. Hedge funds and other institutional investors own 4.35% of the company’s stock.
Analyst Ratings Changes
Get Our Latest Analysis on EUDA
EUDA Health Company Profile
EUDA Health, Inc (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health.
EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation.
See Also
- Five stocks we like better than EUDA Health
- The Metals Company’s Big Bet Now Comes Down to a License
- OneSpaWorld Keeps Turning Cruise Demand Into Record Earnings
- Meta and Tesla Are Rebounding From Oversold Levels—Now What?
- AMG’s Alternatives Boom Powers Record Growth
Receive News & Ratings for EUDA Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EUDA Health and related companies with MarketBeat.com's FREE daily email newsletter.
